medigraphic.com
ISSN 0326-3428 (Print)
Órgano de difusión científica de la Asociación Nefrológica de Buenos Aires

2021, Number 2

<< Back Next >>

Rev Nefrol Dial Traspl 2021; 41 (2)

Peripheral arterial disease in renal transplant patients. Validity of the Edinburgh questionnaire for disease diagnosis

Lema-Verdía L, Balboa-Barreiroa V, Couceiro-Sánchez E, González-Martín C, Pértega-Díaz S, Seoane-Pillado T, Pita-Fernández S

Language: Spanish
References: 39
Page: 100-112
PDF size: 443.10 Kb.


ABSTRACT

Objectives: To assess the prevalence of peripheral artery disease in kidney transplant patients and the validity of intermittent claudication for its diagnosis. Methods: Setting and period: Nephrology Department of the University Hospital A. Coruña, 2013-2017. Inclusion criteria: transplant patients with functioning grafts who gave their consent to participate in the study. Sample size rationale: n=371 patients (confidence interval= 95%; precision= ± 4.25%). Measurements: age, age at the time of transplant, sex, dyslipemia, body mass index, smoking, diabetes, sign of Godet, perimalleolar edema, ankle-brachial index and the Edinburgh Questionnaire. Cardiovascular risk was measured with these scores: Framingham-Wilson, Regicore, SCORE and Dorica. Results: The mean age at the time of transplant was 47.86±12.62; 65.5% of patients were men and 8.7% of them had an ankle-brachial index of ‹0.90. When answering the Edinburgh Questionnaire, 16.2% of subjects reported suffering from intermittent claudication. Concordance between these two diagnostic tests is poor (kappa index= 0.34). The Edinburgh Questionnaire showed a sensitivity of 59.38% in predicting the ankle-brachial index ( ‹0.90) and specificity (88.10%). The variables associated with the presence of artery disease are age at the time of transplant (OR=1.07) and smoking (OR=6.17), dyslipidemia being at the limit of statistical significance. Conclusions: A tenth part of the patients have peripheral artery disease. Concordance between the Edinburgh Questionnaire and the ankle-brachial index is poor; therefore, the latter should be used as diagnostic method. Clinical signs and symptoms underestimate the prevalence of artery disease. Age, smoking and dyslipidemia increase the risk of this disease. Artery disease patients have a higher cardiovascular risk.


REFERENCES

  1. Coppola G, Novo S. Statins and peripheral arterialdisease: effects on claudication, disease progression,and prevention of cardiovascular events. ArchMed Res. 2007;38(5):479-88. doi: 10.1016/j.arcmed.2006.12.012.

  2. Vallejo OG. Utilidad del índice tobillo-brazo para eldiagnóstico de la enfermedad arterial periférica. ClinInvest Arterioscl. 2011;23(1):29-30. doi: 10.1016/j.arteri.2011.03.006.

  3. Maggi DL, Dal Piva de Quadros LR, de OliveiraAzzolin K, Goldmeier S. Índice tornozelo-braquial:estratégia de enfermeiras na identificação dosfatores de risco para doença cardiovascular. Rev EscEnferm USP. 2014;48(2):223-7. doi: 10.1590/s0080-623420140000200004.

  4. Wolfe RA, Ashby VB, Milford EL, Ojo AO, EttengerRE, Agodoa LY, et al. Comparison of mortality inall patients on dialysis, patients on dialysis awaitingtransplantation, and recipients of a first cadaverictransplant. N Engl J Med. 1999;341(23):1725-30. doi:10.1056/NEJM199912023412303.

  5. Mostaza JM, Manzano L, Suárez C, Cairols M,Ferreira EM, Rovira E, et al. Prevalencia de enfermedadarterial periférica asintomática, estimada medianteel índice tobillo-brazo, en pacientes con enfermedadvascular. Estudio MERITO II. Med Clin (Barc).2008;131(15):561-5. doi: 10.1157/13128016.

  6. Félix-Redondo FJ, Fernández-Bergés D, Grau M,Baena-Diez JM, Mostaza JM, Vila J. Prevalenceand clinical characteristics of peripheral arterialdisease in the study population Hermex. Rev EspCardiol (Engl Ed). 2012;65(8):726-33. doi: 10.1016/j.recesp.2012.03.008.

  7. Blanes JI, Cairols MA, Marrugat J; ESTIME.Prevalence of peripheral artery disease and its associatedrisk factors in Spain: The ESTIME Study. Int Angiol.2009;28(1):20-5.

  8. Bendermacher BL, Teijink JA, Willigendael EM,Bartelink ML, Büller HR, Peters RJ, et al. Symptomaticperipheral arterial disease: the value of a validatedquestionnaire and a clinical decision rule. Br J GenPract. 2006;56(533):932-7.

  9. Pita-Fernández S, Modroño-Freire MJ, Pértega-Díaz S,Herrera-Díaz L, Seoane-Pillado T, Paz-Solís A, et al.Validity of the Edinburgh claudication questionnairefor diagnosis of peripheral artery disease in patientswith type 2 diabetes. Endocrinol Diabetes Nutr.2017;64(9):471-9. doi: 10.1016/j.endien.2017.06.003.

  10. Leskinen Y, Salenius JP, Lehtimäki T, Huhtala H,Saha H. The prevalence of peripheral arterial diseaseand medial arterial calcification in patients withchronic renal failure: requirements for diagnostics.Am J Kidney Dis. 2002;40(3):472-9. doi: 10.1053/ajkd.2002.34885.

  11. Basgoz BB, Tasci I, Yildiz B, Acikel C, Kabul HK,Saglam K. Evaluation of self-administered versusinterviewer-administered completion of EdinburghClaudication Questionnaire. Int Angiol. 2017;36(1):75-81. doi: 10.23736/S0392-9590.16.03645-2.

  12. Sociedad Española de Nefrología. Registro Español deEnfermos Renales. Informe de Diálisis y Trasplante 2011[Internet]. Disponible en: https://www.senefro.org/modules/webstructure/files/reercongsen2012.pdf.

  13. Garimella PS, Hart PD, O’Hare A, DeLoach S,Herzog CA, Hirsch AT. Peripheral artery diseaseand CKD: a focus on peripheral artery disease as acritical component of CKD care. Am J Kidney Dis.2012;60(4):641-54. doi: 10.1053/j.ajkd.2012.02.340.

  14. Wattanakit K, Folsom AR, Selvin E, Coresh J,Hirsch AT, Weatherley BD. Kidney function andrisk of peripheral arterial disease: results from theAtherosclerosis Risk in Communities (ARIC) Study.J Am Soc Nephrol. 2007;18(2):629-36. doi: 10.1681/ASN.2005111204.

  15. Lash JP, Go AS, Appel LJ, He J, Ojo A, Rahman M, etal.; Chronic Renal Insufficiency Cohort (CRIC) StudyGroup. Chronic Renal Insufficiency Cohort (CRIC)Study: baseline characteristics and associationswith kidney function. Clin J Am Soc Nephrol.2009;4(8):1302-11. doi: 10.2215/CJN.00070109.

  16. United States Renal Data System. USRDS 2007Annual Data Report: Atlas of Chronic Kidney Diseaseand End-Stage Renal Disease in the United States. AmJ Kidney Dis. 2008;51(1 Suppl. 1): S1-S320.

  17. Snyder JJ, Kasiske BL, Maclean R. Peripheral arterialdisease and renal transplantation. J Am Soc Nephrol.2006;17(7):2056-68. doi: 10.1681/ASN.2006030201.

  18. Wu SW, Lin CK, Hung TW, Tsai HC, Chang HR,Lian JD. Subclinical peripheral arterial disease in renaltransplantation. Am J Med Sci. 2014;347(4):267-70.doi: 10.1097/MAJ.0b013e3182896a33.

  19. Young MJ, Adams JE, Anderson GF, Boulton AJ,Cavanagh PR. Medial arterial calcification in thefeet of diabetic patients and matched non-diabeticcontrol subjects. Diabetologia. 1993;36(7):615-21. doi:10.1007/BF00404070.

  20. Rooke TW, Hirsch AT, Misra S, Sidawy AN,Beckman JA, Findeiss L, et al.; American College ofCardiology Foundation Task Force; American HeartAssociation Task Force. Management of patients withperipheral artery disease (compilation of 2005 and 2011ACCF/AHA Guideline Recommendations): a reportof the American College of Cardiology Foundation/American Heart Association Task Force on PracticeGuidelines. J Am Coll Cardiol. 2013;61(14):1555-70.doi: 10.1016/j.jacc.2013.01.004.

  21. Norgren L, Hiatt WR, Dormandy JA, Nehler MR,Harris KA, Fowkes FG; TASC II Working Group. Inter-Society Consensus for the Management of PeripheralArterial Disease (TASC II). J Vasc Surg. 2007;45(Suppl.S):S5-67. doi: 10.1016/j.jvs.2006.12.037.

  22. Franke GH, Reimer J, Kohnle M, Luetkes P, MaehnerN, Heemann U. Quality of life in end-stage renaldisease patients after successful kidney transplantation:development of the ESRD symptom checklist -transplantation module. Nephron. 1999;83(1):31-9.doi: 10.1159/000045470.

  23. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology ofcardiovascular disease in chronic renal disease. J AmSoc Nephrol. 1998;9(12 Suppl.):S16-23.

  24. Moreno-Carriles RM. Registro de actividad de laSociedad Española de Angiología y Cirugía Vascular,año 2007. Angiología. 2008;60(4):291-316.

  25. Forés R, Alzamora MT, Baena JM, Pera G, ToránP, Ingla J, et al. Infradiagnóstico de la arteriopatíaperiférica en la población española. Estudio ARTPER.Med Clin (Barc). 2010;135(7):306-9. doi: 10.1016/j.medcli.2009.11.046.

  26. Alonso I, Valdivielso P, Zamudio MJ, Sánchez M.A,Pérez F, Ramos H, et al. Rentabilidad del índicetobillo-brazo para la detección de enfermedad arterialperiférica en población laboral de la Junta de Andalucíaen Málaga. Med Clin (Barc). 2009;132(1):7-11. doi:10.1016/j.medcli.2008.02.002.

  27. Vicente I, Lahoz C, Taboada M, García A, San MartínMA, Terol I, et al. Prevalencia de un índice tobillo-brazopatológico según el riesgo cardiovascular calculadomediante la función de Framingham. Med Clin (Barc).2005;124(17):641-4. doi: 10.1157/13074738.

  28. Ramos R, Quesada M, Solanas P, Subirana I, SalaJ, Vila J, et al.; REGICOR Investigators. Prevalenceof symptomatic and asymptomatic peripheral arterialdisease and the value of the ankle-brachial index tostratify cardiovascular risk. Eur J Vasc Endovasc Surg.2009;38(3):305-11. doi: 10.1016/j.ejvs.2009.04.013.

  29. Carbayo JA, Divisón JA, Escribano J, López-AbrilJ, López de Coca E, Artigao LM, et al.; Grupo deEnfermedades Vasculares de Albacete (GEVA).Using ankle-brachial index to detect peripheralarterial disease: prevalence and associated riskfactors in a random population sample. Nutr MetabCardiovasc Dis. 2007;17(1):41-9. doi: 10.1016/j.numecd.2005.08.009.

  30. Puras Mallagray E. Claudicación: epidemiología ehistoria natural. Angiología. 2010;62(Esp Cong):52-6.

  31. Guindo J, Martínez-Ruíz MD, Gusi G, Punti J,Bermúdez P, Martínez-Rubio A. Métodos diagnósticosde la enfermedad arterial periférica. Importancia delíndice tobillo-brazo como técnica de criba. Rev EspCardiol. 2009;9(4):11-1.

  32. Suárez C, Lozano FS (coord.), Bellmunt S, CamafortM, Díaz S, Mancera J, et al. Documento de consensomultidisciplinar entorno a la enfermedad arterialperiférica. 1ª ed. Madrid: Luzán 5, 2012.

  33. Tranche-Iparraguirre S, Marín-Iranzo R, FernándezdeSanmamed R, Riesgo-García A, Hevia-RodríguezE, García-Casas JB. Peripheral arterial disease andkidney failure: a frequent association. Nefrologia.2012;32(3):313-20. doi: 10.3265/Nefrologia.pre2011.

  34. Forés R, Alzamora MT, Pera G, Torán P, Urrea M, Heras A. Concordancia entre 3 métodos de medición del índice tobillo-brazo para el diagnóstico de arteriopatía periférica. Med Clin (Barc). 2014;143(8):335-40. doi: 10.1016/j.medcli.2013.10.029.

  35. Nogales JM. Diagnóstico precoz de la arteriopatíaperiférica mediante la determinación automática delíndice tobillo-brazo. Med Clin (Barc). 2014;143(8):352-53. doi: 10.1016/j.medcli.2014.01.013.

  36. Serrano Hernado FJ, Conejero AM. Enfermedadarterial periférica: aspectos fisiopatológicos, clínicos yterapéuticos. Rev Esp Cardiol. 2007;60(9):969-82. doi:10.1157/13109651.

  37. Kasiske BL, Chakkera HA, Roel J. Explained andunexplained ischemic heart disease risk after renaltransplantation. J Am Soc Nephrol. 2000;11(9):1735-43.

  38. Covic A, Gusbeth-Tatomir P, Goldsmith DJ. Thechallenge of cardiovascular risk factors in end-stagerenal disease. J Nephrol. 2003;16(4):476-86.

  39. Kiberd B, Panek R. Cardiovascular outcomes in theoutpatient kidney transplant clinic: the Framinghamrisk score revisited. Clin J Am Soc Nephrol. 2008;3(3):822-8. doi: 10.2215/CJN.00030108.




2020     |     www.medigraphic.com